We're paving the way to make elevated Lp(a) an actionable biomarker for hereditary cardiovascular risk.
We're expanding access and screening options to help eliminate cervical cancer.
Roche and GenMark are dedicated to providing world-class solutions for multiplex testing.
Test development is a Roche and Lilly collaboration to support earlier Alzheimer’s diagnosis.
Learn more about our portfolio of lab instruments, systems, assays and more
More than 800,000 documents available on demand — always up-to-date with 24/7 access